Combination drug study for advanced solid tumor cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests a combination of two new treatments (QLP2117 and QL2107) for people with advanced solid tumors that have not responded to standard therapy. The goal is to see if the combination can shrink tumors or slow cancer growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer has come back or hasn't responded to standard treatments, or there's no standard treatment available.
- You have at least one tumor that can be measured on imaging scans (like CT or MRI).
- You are able to do your daily activities with little or no help (ECOG score 0 or 1).
- You are willing to provide a sample of your tumor tissue from a past biopsy or surgery.
- You must not have an active autoimmune disease, an active infection, or have had a live vaccine in the past 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two experimental drugs given together to treat advanced solid tumors that have not responded to previous treatments. The goal is to see if the combination helps shrink or control the cancer, and the study is for people who are otherwise in fairly good health.
This trial tests a new drug called QLC5508, given in combination with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy or who haven't had treatment yet. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests a combination of two new drugs (QLS31905 and/or QL1706) with chemotherapy for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if this combination can shrink tumors and help people live longer.
This trial tests an experimental drug (QLS1209) for advanced solid tumors that have not responded to standard treatments or when no standard treatment exists. The study looks for tumors with certain genetic changes (in CCNE1, FBXW7, or PPP2R1A) and may help guide future treatment options.
This trial tests a new combination of drugs for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the combination can shrink tumors and improve outcomes.
This trial tests a new combination of drugs for advanced solid tumors. It may help if your cancer has not responded to other treatments, and the goal is to see how safe and effective this new approach is.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.